Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 51Neoplasms 29Prostatic Neoplasms 28Head and Neck Neoplasms 15Lung Neoplasms 14Ovarian Neoplasms 9Pancreatic Neoplasms 8Urinary Bladder Neoplasms 6Sarcoma 6Oropharyngeal Neoplasms 6Hematologic Neoplasms 6Gastrointestinal Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Neoplasm Metastasis 5Multiple Myeloma 5Esophageal Neoplasms 5Endometrial Neoplasms 5Depression 5Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Polycystic Ovary Syndrome 4Motor Activity 4Melanoma 4Lymphoma 4Anxiety Disorders 4Stomach Neoplasms 3Pain 3Osteosarcoma 3

Interventions

Rituximab 85Cyclophosphamide 80Prednisone 47Doxorubicin 43Lenalidomide 36Vincristine 34Magnetic Resonance Spectroscopy 29polatuzumab vedotin 28Gemcitabine 26Etoposide 26Specimen Handling 25fludarabine 23Biopsy 21Oxaliplatin 20CT-P10 20glofitamab 16tafasitamab 15obinutuzumab 15ibrutinib 13fludarabine phosphate 13zanubrutinib 12axicabtagene ciloleucel 12Immunotherapy, Adoptive 12Ifosfamide 12venetoclax 11pembrolizumab 11deltacortene 11prednylidene 10Prednisolone 10Leukapheresis 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, Large B-Cell, Diffuse × Surveys and Questionnaires × 1 year × Clear all
NCT07588698 2026-05-15

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04319237 2026-03-02

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

H. Lee Moffitt Cancer Center and Research Institute

Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡